Prospects for an HIV Vaccine: Conventional Approaches and DNA Immunization

References

• Agadjanyan , M.G. , Kim , J.J. , Trivedi , N. and Wilson , D.M. 1999 . Monzavi-Karbassi, B., Morrison, L.D., Nottingham, L.K., Dentchev, T., Tsai, A., Dang, K., Chalian, A.A., Maldonado, M.A., Williams, W.V. and Weiner, D.B. CD86 (B7–2) can function to drive MHC-restricted antigen-specific CTL responses in vivo . Journal of Immunology , 162 : 3417 – 3427 .
   PubMed Web of Science ®Google Scholar
• Aibert , M.L. , Pearce , S.F. , Francisco , L.M. and Sauter , B. 1998a . Roy, P., Silverstein, R.L. and Bhardwaj, N. Immature dendritic cells phagocytose apoptotic cells viaalphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes . Journal of Experimental Medicine , 188 : 1359 – 1368 .
   PubMedGoogle Scholar
• Albert , M.L. , Sauter , B. and Bhardwaj , N. 1998b . Dendritic cells acquire antigen from apoplotic cells and induce class I-restricted CTLs . Nature , 392 : 86 – 89 .
   PubMed Web of Science ®Google Scholar
• Alizon , M. and Sonigo , P. 1984 . Barre-Sinoussi, F., Chermann, J.C., Tiollais, P., Montagnier, L. and Wain-Hobson, S. Molecular cloning of lymphadenopathy-associated virus . Nature , 312 : 757 – 760 .
   PubMedGoogle Scholar
• Ayyavoo , V. , Mahalingam , S. and Rafaeli , Y. 1997a . Kudchodkar, S., Chang, D., Nagashunmugam.T., Williams, W.V. and Weiner, D.B. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in Tcells and monocytoid cells in vitro . Journal of Leukocyte Biology , 62 : 93 – 99 .
   PubMedGoogle Scholar
• Ayyavoo , V. , Mahboubi , A. and Mahalingam , S. 1997b . Ramalingam, R., Kudchodkar, S., Williams, W.V., Green, D.R. and Weiner, D.B. HIV-1 Vpr suppresses immune activation and apoplosis through regulation of nuclear factor kappa B . Nature Medicine , 3 : 1117 – 1123 .
   PubMed Web of Science ®Google Scholar
• Banchereau , J. and Steinman , R.M. 1998 . Dendritic cells and the control of immunity . Nature , 392 : 245 – 252 .
   PubMed Web of Science ®Google Scholar
• Barouch , D.H. , Craiu , A. , Kuroda , M.J. , Schmitz , J.E. , Zheng , X.X. and Santra , S. 2000 . Frost, J.D., Krivulka, G.R., Lifton, M.A., Crabbs, C.L., Heidecker, G., Perry, H.C., Davies, M.E., Xie, H., Nickerson, C.E., Steenbeke, T.D., Lord, C.I., Montefiori, D.C., Strom, T.B., Shiver, J.W., Lewis, M.G. and Letvin, N.L. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys . Proceedings of the National Academy of Sciences of the United States of America , 97 : 4192 – 4197 .
   PubMed Web of Science ®Google Scholar
• Bartlett , J.A. , Wasserman , S.S. , Hicks , C.B. , Dodge , R.T. , Weinhold , K.J. , Tacket , C.O. and Ketter , N. 1998 . Wittek, A.E., Palker, T.J. and Haynes, B.F. Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative . AIDS , 12 : 1291 – 1300 .
   PubMed Web of Science ®Google Scholar
• Bernstein , H.B. , Tucker , S.P. , Hunter , E. , Schutzbach , J.S. and Compans , R.W. 1994 . Human immunodeficiency virus type I envelope glycoprotein is modified by O-linked oligosaccharides . Journal of Virology , 68 : 463 – 468 .
   PubMedGoogle Scholar
• Bottarel , F. , Feito , M.J. and Bragardo , M. 1999 . Bonissoni, S., Buonfiglio, D., DeFranco, S., Malavasi, F., Bensi, T, Ramenghi, U. and Dianzani, U. The cell death-inducing ability of glycoprotein 120 from different HIV strains correlates with their ability to induce CD4 lateral association with CD95 on CD4+T cells . AIDS Research and Human Retroviruses , 15 : 1255 – 1263 .
   PubMedGoogle Scholar
• Boyer , J.D. , Ugen , K.E. , Wang , B. , Agadjanyan , M. , Gilbert , L. , Bagarazzi , M.L. and Chattergoon , M. 1997 . Frost, P., Javadian, A., WILLIAMS, W.V., Refaeli, Y., Ciccarelli, R.B., McCallus, D., Coney, L. and Weiner, D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments] . Nature Medicine , 3 : 526 – 532 .
   PubMed Web of Science ®Google Scholar
• Boyer , J.D. , Cohen , A.D. , Ugen , K.E. , Edgeworth , R.L. and Bennett , M. 2000 . Shah, A., Schumann, K., Nath, B., Javadian, A., Bagarazzi, M.L., Kim, J. and Weiner, D.B. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids . AIDS , 14 : 1515 – 1522 .
   PubMedGoogle Scholar
• Buge , S.L. , Murty , L. , Arora , K. , Kalyanaraman , V.S. , Markham , P.D. , Richardson , E.S. and Aldrich , K. 1999 . Patterson, L.J., Miller, C.J., Cheng, S.M. and Robert-Guroff, M. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251 . Journal of Virology , 73 : 7430 – 7440 .
   PubMed Web of Science ®Google Scholar
• Burton , D.R. 1997 . A vaccine for HIV type 1: the antibody perspective . Proceedings of the National Academy of Sciences of the United Stares of America , 94 : 10018 – 10023 .
   PubMed Web of Science ®Google Scholar
• Caley , I.J. , Betts , M.R. , Irlbeck , D.M. , Davis , N.L. and Swanstrom , R. 1997 . Frelinger, J.A. and Johnston, R.E. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector . Journal of Virology , 71 : 3031 – 3038 .
   PubMed Web of Science ®Google Scholar
• Cao , Y. , Qin , L. , Zhang , L. , Safrit , J. and Ho , D.D. 1995 . Virologic and Immunologie characterization of long-term survivors of human immunodeficiency virus type 1 infection [see comments] . New England Journal of Medicine , 332 : 201 – 208 .
   PubMed Web of Science ®Google Scholar
• Carbone , F.R. and Bevan , M.J. 1990 . Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo . Journal of Experimental Medicine , 171 : 377 – 387 .
   PubMed Web of Science ®Google Scholar
• Carmichael , A. , Jin , X. , Sissons , P. and Borysiewicz , L. 1993 . Quantitative analysis of the human immunodeficiency virus type I (HlV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV- I infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease . Journal of Experimental Medicine , 177 : 249 – 256 .
   PubMed Web of Science ®Google Scholar
• Casares , S. , Inaba , K. , Brumeanu , T.D. , Steinman , R.M. and Bona , C.A. 1997 . Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope . Journal of Experimental Medicine , 186 : 1481 – 1486 .
   PubMed Web of Science ®Google Scholar
• Cayabyab , M. , Karlsson , G.B. , Etemad-Moghadam , B.A. and Hofmann , W. 1999 . Steenbeke, T., Halloran, M., Fanton, J.W., Axthelm, M.K., Letvin, N.L. and Sodroski, J.G. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2) . Journal of Virology , 73 : 976 – 984 .
   PubMedGoogle Scholar
• Chan , D.C and Kim , P.S. 1998 . HIV entry and its inhibition . Cell , 93 : 681 – 684 .
   PubMed Web of Science ®Google Scholar
• Chan , D.C. and Fass , D. 1997 . Berger, J.M.and Kim, P.S. Core structure of gp41 from die HIV envelope glycoprotein . Cell , 89 : 263 – 273 .
   PubMed Web of Science ®Google Scholar
• Chow , Y.H. , Huang , W.L. , Chi , W.K. , Chu , Y.D. and Tao , M.H. 1997 . Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2 . Journal of Virology , 71 : 169 – 178 .
   PubMed Web of Science ®Google Scholar
• Condon , C. , Watkins , S.C. , Celluzzi , C.M. and Thompson , K. 1996 . and Falo, L.D. Jr.DNA-based immunization by in vivo transfection of dendritic cells . Nature Medicine , 2 : 1122 – 1128 .
   PubMed Web of Science ®Google Scholar
• Davis , H.L. , Michel , M.L. , Mancini , M. , Schleef , M. and Whalen , R.G. 1994 . Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen . Vaccine , 12 : 1503 – 1509 .
   PubMedGoogle Scholar
• Davis , N.L. , Caley , I.J. , Brown , K.W. , Betts , M.R. , Irlbeck , D.M. , McGratih , K.M. , Connell , M.J. , Montefiori , D.C. , Frelinger , J.A. and Swanstrom , R. 2000 . Johnson, P.R. and Johnston, R.E. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles [erratum appears in Journal of Virology 2000 Apr;74(7):3430] . Journal of Virology , 74 : 371 – 378 .
   PubMed Web of Science ®Google Scholar
• Deck , R.R. 1997 . DeWiit. C.M., Donnelly, J.J., Liu, M.A. and Ulmer, J.B. Characterization of humoral immune responses induced hy an influenza hemagglutinin DNA vaccine . Vaccine , 15 : 71 – 78 .
   PubMed Web of Science ®Google Scholar
• Demini , E.A. , Schleif , W.A. , Nunberg , J.H. , Conley , A.J. and Eda , Y. 1992 . Tokiyoshi, S., Putney, S.D., Matsushita, S., Cobb, K.E. and Jett, C.M. Prevention of HIV-1 infection in chimpanzees hy gp120 V3 domain-specific monoclonal antihody . Nature , 355 : 728 – 730 .
   PubMedGoogle Scholar
• Edinger , A.L. , Amedee , A. , Miller , K. , Doranz , B.J. and Endres , M. 1997 . Sharron. M., Samson, M., Lu, Z.H., Clements, J.E., Murphey-Corb, M., Peiper, S.C., Parmentier, M., Broder, C.C. and DOMS, R.W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains . Proceedings of the National Academy of Sciences of the United States of America , 94 : 4005 – 4010 .
   PubMed Web of Science ®Google Scholar
• Feltquate , D.M. , Heaney , S. , Webster , R.G. and Robinson , H.L. 1997 . Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization . Journal of Immunology , 158 : 2278 – 2284 .
   PubMed Web of Science ®Google Scholar
• Ferrari , G. and Ottinger , J. 1993 . Place. C., Nigida, S.M., Arthur, L.O. and Weinhold, K.J. The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees . AIDS Research and Human Retroviruses , 9 : 647 – 656 .
   PubMedGoogle Scholar
• Frankel , F.R. , Hegde , S. , Lieberman , J. and Paterson , Y. 1995 . Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector . Journal of Immunology , 155 : 4775 – 4782 .
   PubMed Web of Science ®Google Scholar
• Fuller , D.H. and Haynes , J.R. 1994 . A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine . AIDS Research and Human Retroviruses , 10 : 1433 – 1441 .
   PubMed Web of Science ®Google Scholar
• Fultz , P.N. , McClure , H.M. , Swenson , R.B. and Anderson , D.C. 1989 . HIV infection of chimpanzees as a model for testing chemotherapeutics . Intevirology , 30 ( Suppl 1 ) : 51 – 58 .
   PubMedGoogle Scholar
• Fynan , E.F. , Webster , R.G. , Fuller , D.H. , Haynes , J.R. , Santoro , J.C. and Robinson , H.L. 1993 . DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations . Proceedings of the National Academy of Sciences of the United Slates of America , 90 : 11478 – 11482 .
   PubMed Web of Science ®Google Scholar
• Gandhi , R.T. , Chen , B.K. , Straus , S.E. , Dale , J.K. , Lenardo , M.J. and Baltimore , D. 1998 . HIV-1 directly kills CD4+T cells by a Fas-independent mechanism . Journal of Experimental Medicine , 187 : 1113 – 1122 .
   PubMedGoogle Scholar
• Gao , F. , Bailes , E. , Robertson , D.L. and Chen , Y. 1999 . Rodenburg, C.M., Mschael, S.F., Cummins, L.B., Arthur, L.O., Peeters, M., Shaw, G.M., Sharp, P.M. and Hahn, B.H. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes [see comments] . Nature , 397 : 436 – 441 .
   PubMed Web of Science ®Google Scholar
• Geissler , M. , Gesien , A. , Tokushsge , K. and Wands , J.R. 1997 . Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids . Journal of Immunology , 158 : 1231 – 1237 .
   PubMed Web of Science ®Google Scholar
• Geleziunas , R. , Xu , W. , Takeda , K. , Ichijo , H. and Greene , W.C. 2001 . HIV-1 Nef inhibits ASK1 -dependent death signalling providing a potential mechanism for protecting the infected host cell . Nature , 410 : 834 – 838 .
   PubMed Web of Science ®Google Scholar
• Haigwood , N.L. , Watson , A. , Sutton , W.F. and McClure , J. 1996 . Lewis, A., Ranchalis. J., Travis, B., Voss, G., Letvin, N.L., Hu, S.L., Hirsch, V.M. and Johnson, P.R. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile . Immunology Letters , 51 : 107 – 114 .
   PubMed Web of Science ®Google Scholar
• Harrer , T. , Harrer , E. , Kalams , S.A. and Elbeik , T. 1996 . Staprans, S.I., Feinberg, M.B., Cao, Y., Ho, D.D., Yilma, T., Caliendo, A.M., Johnson, R.P., Buchbinder, S.P. and Walker, B.D. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection . AIDS Research and Human Retroviruses , 12 : 585 – 592 .
   PubMed Web of Science ®Google Scholar
• He , J. , Choe , S. and Walker , R. 1995 . Di Marzio, P., Morgan, D.O. and Landau, N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity . Journal of Virology , 69 : 6705 – 6711 .
   PubMed Web of Science ®Google Scholar
• Hemmi , H. , Takeuchi , O. and Kawai , T. 2000 . Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. A toll-like receptor recognizes bacterial DNA [see comments] . Nature , 408 : 740 – 745 .
   PubMed Web of Science ®Google Scholar
• Hirsch , V.M. , Fuerst , T.R. , Sutter , G. , Carroll , M.W. , Yang , L.C. and Goldstein , S. 1996 . Piatak, M., Elkins, W.R., Alvord, W.G., Montefiori, D.C., MOSS, B. and Lifson, J.D. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara . Journal of Virology , 70 : 3741 – 3752 .
   PubMed Web of Science ®Google Scholar
• Hu , S.L. , Fultz , P.N. , McClure , H.M. , Eichberg , J.W. , Thomas , E.K. and Zarlino , J. 1987 . Singhal, M.C., Kosowski, S.G., Swenson, R.B. and Anderson, D.C. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees . Nature , 328 : 721 – 723 .
   PubMed Web of Science ®Google Scholar
• Hu , S.L. , Abrams , K. , Barber , G.N. and Moran , P. 1992 . Zarling, J.M., Langlois, A.J., Kuller, L., Morton, W.R. and Benveniste, R.E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160 . Science , 255 : 456 – 459 .
   PubMed Web of Science ®Google Scholar
• Huang , A.Y. , Golumbek , P. , Ahmadzadeh , M. , Jaffee , E. , Pardoll , D. and Levitsky , H. 1994 . Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens . Science , 264 : 961 – 965 .
   PubMed Web of Science ®Google Scholar
• Igarashi , T. , Brown , C. and Azadegan , A. 1999 . Haigwood, N., Dimitrov, D., Martin, M.A. and Shibata, R. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma [see comments.] . Nature Medicine , 5 : 211 – 216 .
   PubMedGoogle Scholar
• Javaherian , K. , Langlois , A.J. , LaRosa , G.J. , Profy , A.T. , Bolognesi , D.P. , Herlihy , W.C. , Putney , S.D. and Matthews , T.J. 1990 . Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-l [erratum appears in Science 1991 Jan 4;251(4989):13] . Science , 250 : 1590 – 1593 .
   PubMed Web of Science ®Google Scholar
• Jin , X. , Bauer , D.E. , Tuttleton , S.E. and Lewin , S. 1999 . Gettie, A., Blanchard, J., Irwin, C.E., Safrit, J.T., Mittler, J., Weinberger, L., Kostrikis, L.G., Zhang, L., Perelson, A.S. and Ho, D.D. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques . Journal of Experimental Medicine , 189 : 991 – 998 .
   PubMed Web of Science ®Google Scholar
• Johnson, P., Schnepp, B., Montefiori, D., Letvin, N. and Clark, R. (2001). SIV vaccines based on adeno-associated virus vectors. Paper presented at: AIDS Vaccine 2001 (Philadelphia PA)
   Google Scholar
• Kalams , S.A. and Walker , B.D. 1998 . The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses . Journal of Experimental Medicine , 188 : 2199 – 2204 .
   PubMed Web of Science ®Google Scholar
• Katsumi , A. , Emi , N. and Abe , A. 1994 . Hasegawa, Y., Ito, M. and Saito, H. Humoral and cellular immunity to an encoded protein induced by direct DNA injection . Human Gene Therapy , 5 : 1335 – 1339 .
   PubMed Web of Science ®Google Scholar
• Kim , J.J. , Ayyavoo , V. , Bagarazzi , M.L. , Chattergoon , M.A. and Dang , K. 1997a . Wang, B., Boyer, J.D. and Weiner, D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen . Journal of Immunology , 158 : 816 – 826 .
   PubMed Web of Science ®Google Scholar
• 1997b . Kim, J, J., Bagarazzi, M.L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D.M., Ciccarelli, R., Chattergoon, M.A., Dang, K., Mahalingam, S., Chalian, A.A., Agadjanyan, M, G., Boyer, J, D., Wang, B. and Weiner, D.B. Engineering of in vivo immune responses to DNA immunization via codelivery of coslimuiatory molecule genes . Nature Biotechnology , 15 : 641 – 646 .
   PubMed Web of Science ®Google Scholar
• Kim , J.J. , Nottingham , L.K. , Tsai , A. , Lee , D.J. , Maguire , H.C. and Oh , J. 1999 . Dentchev, T., Manson, K.H., Wyand, M.S., Agadjanyan, M.G., Ugen, K.E. and Weiner, D.B. Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants . Journal of Medical Primatology , 28 : 214 – 223 .
   PubMed Web of Science ®Google Scholar
• Kim , J.J. , Yang , J.S. , Nottingham , L.K. , Lee , D.J. and Lee , M. 2001 . Manson, K.H., Wyand, M.S., Boyer, J.D., Ugen, K.E. and Weiner, D.B. Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization . Virology , 285 : 204 – 217 .
   PubMed Web of Science ®Google Scholar
• Klinman , D.M. , Yamshchikov , G. and Ishigatsubo , Y. 1997 . Contribution of CpG motifs to the immunogenicity of DNA vaccines . Journal of Immunology , 158 : 3635 – 3639 .
   PubMed Web of Science ®Google Scholar
• Koup , R.A. , Safrit , J.T. , Cao , Y. and Andrews , C.A. 1994 . McLeod, G-, Borkowsky, W., Farthing, C. and Ho, D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome . Journal of Virology , 68 : 4650 – 4655 .
   PubMed Web of Science ®Google Scholar
• 1995 . Kovacsovics-Bankowski, M. and Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules . Science , 267 : 243 – 246 .
   PubMed Web of Science ®Google Scholar
• Krieg , A.M. 1996 . An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA . Journal of Laboratory and Clinical Medicine , 128 : 128 – 133 .
   PubMed Web of Science ®Google Scholar
• Kuwata , T. and Shioda , T. 1996 . Igarashi. T., Ido, E., Ibuki, K., Enose, Y., Stahl-Hennig, C., Hunsmann, G., Miura, T. and Hayami, M. Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1 . AIDS , 10 : 1331 – 1337 .
   PubMedGoogle Scholar
• Kwong , P.D. and Wyatt , R. 1998 . Robinson. J., Sweet, R.W., Sodroski, J. and Hendrickson, W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody . Nature , 393 : 648 – 659 .
   PubMed Web of Science ®Google Scholar
• LaRosa , G.J. , Davide , J.P. , Weinhold , K. , Waterbury , J.A. , Profy , A.T. , Lewis , J.A. , Langlois , A.J. , Dreesman , G.R. , Boswell , R.N. and Shadduck , P. 1990 . Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant [erratum appears in Science 1991 Feb 15;251(4995):811] . Science , 249 : 932 – 935 .
   PubMed Web of Science ®Google Scholar
• Leclhrc , C. , Deriaud , E. , Rojas , M. and Whalen , R.G. 1997 . The preferential induction of a Thl immune response by DNA-based immunization is mediated by the immunoslimulatory effect of plasmid DNA . Cellular Immunology , 179 : 97 – 106 .
   PubMedGoogle Scholar
• Leonard , C.K. , Spellman , M.W. , Riddle , L. , Harris , R.J. , Thomas , J.N. and Gregory , T.J. 1990 . Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells . Journal of Biological Chemistry , 265 : 10373 – 10382 .
   PubMed Web of Science ®Google Scholar
• Letvin , N.L. , Montefiori , D.C. , Yasutomi , Y. , Perry , H.C. , Davies , M.E. and Lekutis , C. 1997 . Alroy, M., Freed, D.C., Lord, C.I., Handt, L.K., Liu, M.A. and Shiver, J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination . Proceedings of the National Academy of Sciences of the United States of America , 94 : 9378 – 9383 .
   PubMed Web of Science ®Google Scholar
• Levy , D.N. 1995 . Refaeli. Y. and Weiner, D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency . Journal of Virology , 69 : 1243 – 1252 .
   PubMed Web of Science ®Google Scholar
• Lu , M. and Kim , P.S. 1997 . A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein . Journal of Biomolecular Structure & Dynamics , 15 : 465 – 471 .
   PubMed Web of Science ®Google Scholar
• Martin , T. , Parker , S.E. and Hedstrom , R. 1999 . Le, T., Hoffman, S.L., Norman, J., Hobart, P. and Lew, D. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection . Human Gene Therapy , 10 : 759 – 768 .
   PubMed Web of Science ®Google Scholar
• Marx , P.A. , Munn , R.J. and Joy , K.I. 1988 . Computer emulation or thin section electron microscopy predicts an envelope-associated icosadeltahedral capsid for human immunodeficiency virus . Laboratory Investigation , 58 : 112 – 118 .
   PubMedGoogle Scholar
• Mascola , J.R. , Lewis , M.G. , Stiegler , G. and Harris , D. 1999 . VanCott T.C., Hayes, D., Louder, M.K., Brown, C.R., Sapan.C V., Frankel. S.S., Lu, Y., Robb, M.L., Katinger. H. and Birx, D.L. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies . Journal of Virology , 73 : 4009 – 1018 .
   PubMed Web of Science ®Google Scholar
• Mata , M. and Paterson , Y. 1999 . Thl Tcell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listeria] antigens . Journal of Immunology , 163 : 1449 – 1456 .
   PubMedGoogle Scholar
• Mata , M. , Yao , Z.J. , Zubair , A. and Syres , K. 2001 . and Pathrson, Y.Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge . Vaccine , 19 : 1435 – 1445 .
   PubMed Web of Science ®Google Scholar
• Matano , T. , Shibata , R. and Siemon , C. 1998 . Connors, M., Lane, H.C. and Martin, M. A. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques . Journal of Virology , 72 : 164 – 169 .
   PubMed Web of Science ®Google Scholar
• Moore , J.P. and Burton , D.R. 1999 . HIV-1 neutralizing antibodies: how full is the botlle? [letter; comment] . Nature Medicine , 5 : 142 – 144 .
   PubMed Web of Science ®Google Scholar
• Moore , J.P. , Cao , Y. , Qing , L. , Sattentau , Q.J. and Pyati , J. 1995 . Koduri, R., Robinson, J.,Barbas, C.F., Burton, D.R. and Ho, D.D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120 . Journal of Virology , 69 : 101 – 109 .
   PubMed Web of Science ®Google Scholar
• Mor , G. 1997 . Singla, M, Steinberg, A.D., Hoffman, S.L., Okuda, K. and Klinman, D.M. Do DNA vaccines induce autoimmune disease? . Human Gene Therapy , 8 : 293 – 300 .
   PubMed Web of Science ®Google Scholar
• Mwaengo , D.M. and Novembre , F.J. 1998 . Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections . Journal of Virology , 72 : 8976 – 8987 .
   PubMedGoogle Scholar
• Nichols , W.W. , Ledwith , B.J. , Manam , S.V. and Troilo , P.J. 1995 . Potential DNA vaccine integration into host cell genome . New York Academy of Sciences. Annals , 772 : 30 – 39 .
   PubMed Web of Science ®Google Scholar
• Nyambi , P.N. , Mbah , H.A. , Burda , S. , Williams , C. , Gorny , M.K. and Nadas , A. 2000 . and Zolla-Pazner, S.Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M . Journal of Virology , 74 : 7096 – 7107 .
   PubMedGoogle Scholar
• Pardoll , D.M. and Beckerleg , A.M. 1995 . Exposing the immunoiogy of naked DNA vaccines . Immunity , 3 : 165 – 169 .
   PubMed Web of Science ®Google Scholar
• Parren , P.W. , Mondor , I. , Naniche , D. , Ditzel , H.J. , Klasse , P.J. , Burton , D.R. and Sattentau , Q.J. 1998 . Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity . Journal of Virology , 72 : 3512 – 3519 .
   PubMed Web of Science ®Google Scholar
• Parren , P.W. , Moore , J.P. , Burton , D.R. and Sattentau , Q.J. 1999 . The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity . AIDS , 13 ( Suppl AS ) : 137 – 162 .
   PubMedGoogle Scholar
• Pialoux , G. , Excler , J.L. and Riviere , Y. 1995 . Gonzalez-Canali, G., Feuillie, V., Coulaud, P., Gluckman, J.C., Matthews, T.J., Meignier, B., Kieny, M.P., Gonnet, P., Diaz, I., Meric, C., Paoletti, E., Tartaglia, J., Salomon, H., Plotkin, S., The Agis Group and L’Agence Nationale De Recherche Sur Le SIDA. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and 1’Agence Nationale de Recherche sur le SIDA . AIDS Research and Human Retroviruses , 11 : 373 – 381 .
   PubMed Web of Science ®Google Scholar
• Putney , S.D. , Matthews , T.J. , Robey , W.G. and Lynn , D.L. 1986 . Robert-Guroff, M., Mueller, W.T., Langlois, A.J., Ghrayeb, J., Petteway, S.R. Jr., Weinhold, K.J., Fischinger, P.J., Wong-Stall, F., Gallo, R.C. and Bolognesi, D.P. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope . Science , 234 : 1392 – 1395 .
   PubMed Web of Science ®Google Scholar
• Redfield , R.R. , Wright , D.C. , James , W.D. , Jones , T.S. , Brown , C. and Burke , D.S. 1987 . Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease . New England Journal of Medicine , 316 : 673 – 676 .
   PubMed Web of Science ®Google Scholar
• Reitter , J.N. , Means , R.E. and Desrosiers , R.C. 1998 . A role for carbohydrates in immune evasion in AIDS . Nature Medicine , 4 : 679 – 684 .
   PubMed Web of Science ®Google Scholar
• Rinaldo , C. , Huang , X.L. , Fan , Z.F. and Ding , M. 1995 . Beltz, L., Logar, A., Panicali, D., Mazzara, G., Liebmann, J., Cottrill, M. and Gupta, P. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocytc activity and low viral load are associated with lack of disease in HIV-1-infectcd long-term nonprogressors . Journal of Virology , 69 : 5838 – 5842 .
   PubMed Web of Science ®Google Scholar
• Rizzuto , C.D. and Wyatt , R. 1998 . Hernandez-Ramos, N., Sun, Y., Kwong, P.D., Hendrickson, W.A. and Sodroski, J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding . Science , 280 : 1949 – 1953 .
   PubMed Web of Science ®Google Scholar
• Robinson , H.L. , Boyle , C.A. , Feltquate , D.M. , Morin , M.J. , Santoro , J.C. and Webster , R.G. 1997 . DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs . Journal of Infectious Diseases , 176 ( Suppl 1 ) : 550 – 555 .
   Google Scholar
• Roman , M. 1997 . Martin-Orozco, E., Goodman, J.S., Nguyen, M.D., Sato, Y., Ronaghy, A., Kornbluth, R.S., Richman, D.D., Carson, D. A. and Raz, E. Immunostimulaiory DNA sequences function as Thelper-1 -promoting adjuvants . Nature Medicine , 3 : 849 – 854 .
   PubMed Web of Science ®Google Scholar
• Rosenberg , E.S. , LaRosa , L. , Flynn , T. , Robbins , G. and Walker , B.D. 1999 . Characterization of HIV-1-specific T-helper cells in acute and chronic infection . Immunology Letters , 66 : 89 – 93 .
   PubMedGoogle Scholar
• 1999 . Rowland-Jones, S. Long-term non-progression in HIV infection: clinico pathological issues . Journal of Infection , 38 : 67 – 70 .
   PubMedGoogle Scholar
• Saksela , K. , Cheng , G. and Baltimore , D. 1995 . Prolinc-rich (PxxP) motifs in HIV-1 Ncf bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+viruses but not for down-regulation of CD4 . EMBO Journal , 14 : 484 – 491 .
   PubMed Web of Science ®Google Scholar
• Sanhadji , K. , Grave , L. , Touraine , J.L. and Lejssner , P. 2000 . Rouzioux, C., Firouzi, R., Kehrli, L., Tardy, J.C. and Mehtali, M. Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice . AIDS , 14 : 2813 – 2822 .
   PubMedGoogle Scholar
• Saphire , E.O. , Parren , P.W. , Pantophlet , R. , Zwick , M.B. , Morris , G.M. and Rudd , P.M. 2001 . Dwek, R, A., Stanfield, R.L., Burton, D.R. and Wilson, I. A. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design . Science , 293 : 1155 – 1159 .
   PubMed Web of Science ®Google Scholar
• Sarngadharan , M.G. , DeVico , A.L. , Bruch , L. , Schupbach , J. and Gallo , R.C. 1984 . HTLV-III: the etiologic agent of AIDS . Princess Takamatsu Symposium , 15 : 301 – 308 .
   PubMedGoogle Scholar
• Sato , Y. , Roman , M. and Tighe , H. 1996 . Lee, D., Corr, M., Nguyen, M.D., Silverman, G.J., Lotz, M., Carson, D.A. and Raz, E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization . Science , 273 : 352 – 354 .
   PubMed Web of Science ®Google Scholar
• Sawai , E.T. , Baur , A.S. , Peterlin , B.M. and Levy , J.A. 1995 . Cheng-Mayer, C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity . Journal of Biological Chemistry , 270 : 15307 – 15314 .
   PubMed Web of Science ®Google Scholar
• Schmitz , J.E. , Kuroda , M.J. , Santra , S. , Sasseville , V.G. , Simon , M.A. , Lifton , M.A. and RACZ , P. 1999 . Tenner-Racz, K., Dalesandro, M., Scallon, B.J., Grayeb, J., Forman, M.A., Montefiori, D.C., Rieber, E.P., Letvin, N.L. and Reimann, K.A. Control of viremia in simian immunodeficiency virus infection by CD8+lymphocytes . Science , 283 : 857 – 860 .
   PubMed Web of Science ®Google Scholar
• Shen , L. , Chen , Z.W. , Miller , M.D. and Stallard , V. 1991 . Mazzara, G.P., Panicali, D.L. and Letvin, N.L. Recombinant virus vaccine-induced SIV-specific CD8+cytotoxic T lymphocytes . Science , 252 : 440 – 443 .
   PubMed Web of Science ®Google Scholar
• Shibata , R. , Sibmon , C. , Cho , M.W. , Arthur , L.O. and Nigida , S.M. 1996 . Jr., Matthews, T., Sawyer, L.A., Schultz, A., Murthy, K.K., Israel, Z., Javadian, A., Frost, P., Kennedy, R.C., Lane, H.C and Martin, M.A. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1 . Journal of Virology , 70 : 4361 – 369 .
   PubMed Web of Science ®Google Scholar
• Shibata , R. , Igarashi , T. and Haigwood , N. 1999 . Buckler-White, A., Ogert, R., Ross, W., Willey, R., Cho, M.W. and Martin, M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV- 1/SIV chimeric virus infections of macaque monkeys . Nature Medicine , 5 : 204 – 210 .
   PubMed Web of Science ®Google Scholar
• Shiver , J.W. , Fu , T.M. , Chen , L. , Casimiro , D.R. , Davies , M.E. , Evans , R.K. , Zhang , Z.Q. , Simon , A.J. , Trigona , W.L. , Dubby , S.A. and Huang , L. 2002 . Harris, V.A., Long, R.S., Liang, X., Handt, L., Schleif, W.A., Zhu. L., Freed, D.C. Persaud, N.V., Guan, L., Punt, K.S., Tang, A., Chen, M., Wilson, K.A., Collins, K.B., Heidecker, G.J., Fernandez, V.R., Perry, H.C., Joyce, J.G., Grimm, K.M., Cook, J.C., Keller, P.M., Kresock. D.S., Mach, H., Troutman, R.D., Isopi, L.A., Williams, D.M., Xu, Z., Bohannon, K.E., Volkin, D.B., Montefiori, D.C., Miura, A., Krivulka, G.R., Lifton, M.A., Kuroda, M.J., Schmitz, J.E., Letvin, N.L., Caulfield, M.J., Bett, A.J., Youil, R., Kaslow, D.C. and Emini, E.A. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity . Nature , 415 : 331 – 335 .
   PubMed Web of Science ®Google Scholar
• Suto , R. and Srivastava , P.K. 1995 . A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides . Science , 269 : 1585 – 1588 .
   PubMed Web of Science ®Google Scholar
• Thali , M. , Moore , J.P. and Furman , C. 1993 . Charles, M., Ho, D.D., Robinson, J. and Sodroski, J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding . Journal of Virology , 67 : 3978 – 3988 .
   PubMedGoogle Scholar
• Torres , C.A. , Iwasaki , A. , Barber , B.H. and Robinson , H.L. 1997 . Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations . Journal of Immunology , 158 : 4529 – 532 .
   PubMed Web of Science ®Google Scholar
• Trkola , A. , Pomales , A.B. and Yuan , H. 1995 . Korber, B., Maddon, P.J., Allaway, G.P., Katinger, H., Barbas, C.F. 3rd, Burton, D.R., Ho, D.D. and Moore, J.P. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG . Journal of Virology , 69 : 6609 – 6617 .
   PubMed Web of Science ®Google Scholar
• Ulmer , J.B. , Donnelly , J.J. , Parker , S.E. , Rhodes , G.H. , Felgner , P.L. , Dwarki , V.J. , Gromkowski , S.H. , Deck , R.R. , DeWitt , C.M. and Friedman , A. 1993 . Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L. and Liu, M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein . Science , 259 : 1745 – 1749 .
   PubMed Web of Science ®Google Scholar
• Van Rompay , K.K. 1998 . Berardi C.J., Dillard-Telm. S., Tarara, R.P., Canfield, D.R., Valverde, C.R., Montefiori, D.C., Cole, K.S., Montelaro, R.C., Miller, C.J. and Marthas, M.L. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection . Journal of Infectious Diseases , 177 : 1247 – 1259 .
   PubMed Web of Science ®Google Scholar
• Walker , M.C. , Walker , B.D. , Mestecky , J. and Mathieson , B.J. 1994 . Conference on advances in AIDS vaccine development - 1993. Summary: cytotoxic T-cell immunity workshop . AIDS Research and Human Retroviruses , 10 ( Suppl 2 ) : S177 – 179 .
   Google Scholar
• Walker, M.C., Fast, P.E., Graham, B., Belshe, R. and Dolin, R. (1995). Phase 1/11 preventative vaccine trials. Paper presented at: AIDS Research and Human Retroviruses
   Google Scholar
• Willey , R.L. , Maldarelli , F. , Martin , M.A. and Strebel , K. 1992 . Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes . Journal of Virology , 66 : 226 – 234 .
   PubMed Web of Science ®Google Scholar
• Wu , S. , Pascual , D.W. , Lewis , G.K. and Hone , D.M. 1997 . Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmoncila-HIV vector . AIDS Research and Human Retroviruses , 13 ( 1 ) : 187 – 1194 .
   PubMedGoogle Scholar
• Xiang , Z.Q. , Spitalnik , S.L. , Cheng , J. , Erikson , J. , Wojczyk , B. and Ertl , H.C. 1995 . Immune responses to nucleic acid vaccines to rabies virus . Virology , 209 : 569 – 579 .
   PubMed Web of Science ®Google Scholar
• Yang , X. , Wyatt , R. and Sodroski , J. 2001 . Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers . Journal of Virology , 75 : 1165 – 1171 .
   PubMed Web of Science ®Google Scholar
• Yasutomi , Y. , Koenig , S. , Haun , S.S. , Stover , C.K. , Jackson , R.K. and Conard , P. 1993 . Conley, A.J., Emini, E.A., Fuerst.T.R. and Letvin, N.L. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys . Journal of Immunology , 150 : 3101 – 3107 .
   PubMed Web of Science ®Google Scholar
• Zagury , D. , Bernard , J. and Leibowitch , J. 1984 . Safai, B., Groopman, J.E., Feldman, M., Sarngadharan, M.G. and Gallo, R.C. HTLV-III in cells cutured from sernen of two patients with AIDS . Science , 226 : 449 – 451 .
   PubMed Web of Science ®Google Scholar
• Zolla-Pazner , S. 1999 . Gorny, M.K., Nyambi, P.N., Vancott, T.C and Nadas, A. Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to Immunologie classification of HIV . Journal of Virology , 73 : 4042 – 4051 .
   PubMedGoogle Scholar